Related Experiment Video
Updated: May 21, 2026
07:30
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Drug-induced hypoglycaemia in type 2 diabetes
Berit Inkster1, Nicola N Zammitt, Brian M Frier
1Royal Infirmary of Edinburgh, Department of Diabetes, 51 Little France Crescent, Edinburgh, EH16 4SA, UK.
Expert Opinion on Drug Safety
|June 14, 2012
Summary
Hypoglycaemia, a dangerous side effect of type 2 diabetes medications, can hinder treatment goals. Future therapies should prioritize safety and accurately measure hypoglycaemia risk.
Area of Science:
- Endocrinology
- Pharmacology
- Metabolic Disorders
Background:
- Hypoglycaemia is a significant adverse event associated with type 2 diabetes pharmacotherapy.
- It can lead to physical, social, and psychological distress, impeding glycemic control and treatment success.
Purpose of the Study:
- To review the risk of hypoglycaemia with common type 2 diabetes medications.
- To discuss co-prescribed drugs and patient-specific risk factors for hypoglycaemia.
Main Methods:
- Literature review of commonly prescribed type 2 diabetes therapies (excluding insulin).
- Analysis of co-medications (antihypertensives, antibiotics, fibrates) and patient-related risk factors.
Main Results:
- Certain type 2 diabetes medications carry a risk of hypoglycaemia.
- Co-prescribed drugs and individual patient factors can influence hypoglycaemia risk.
Conclusions:
- Hypoglycaemia is a common, serious complication of some diabetes treatments.
- Therapy selection must consider individual risk, and future research needs accurate hypoglycaemia assessment.
- Developing safer anti-diabetic agents is a priority.
Related Concept Videos
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...